Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL

Stefano Romeo, Len A. Pennacchio, Yunxin Fu, Eric Boerwinkle, Anne Tybjaerg-Hansen, Helen H. Hobbs, Jonathan C. Cohen

Research output: Contribution to journalArticle

386 Scopus citations

Abstract

Resequencing genes provides the opportunity to assess the full spectrum of variants that influence complex traits. Here we report the first application of resequencing to a large population (n = 3,551) to examine the role of the adipokine ANGPTL4 in lipid metabolism. Nonsynonymous variants in ANGPTL4 were more prevalent in individuals with triglyceride levels in the lowest quartile than in individuals with levels in the highest quartile (P = 0.016). One variant (E40K), present in ∼3% of European Americans, was associated with significantly lower plasma levels of triglyceride and higher levels of high-density lipoprotein cholesterol in European Americans from the Atherosclerosis Risk in Communities Study and in Danes from the Copenhagen City Heart Study. The ratio of nonsynonymous to synonymous variants was higher in European Americans than in African Americans (4:1 versus 1.3:1), suggesting population-specific relaxation of purifying selection. Thus, resequencing of ANGPTL4 in a multiethnic population allowed analysis of the phenotypic effects of both rare and common variants while taking advantage of genetic variation arising from ethnic differences in population history.

Original languageEnglish (US)
Pages (from-to)513-516
Number of pages4
JournalNature genetics
Volume39
Issue number4
DOIs
StatePublished - Apr 1 2007

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL'. Together they form a unique fingerprint.

  • Cite this